ArticleScience advances2022

Deubiquitinase CYLD acts as a negative regulator of dopamine neuron survival in Parkinson's disease.

Sheila K Pirooznia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.